Jose M de la Torre Hernandez

Summary

Country: Spain

Publications

  1. doi request reprint Effectiveness and safety beyond 10 years of percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy
    Jose M de la Torre Hernandez
    Unidad de Hemodinámica y Cardiología Intervencionista, Servicio de Cardiologia, Hospital Universitario Marques de Valdecilla, Santander, Spain Electronic address
    Rev Esp Cardiol (Engl Ed) 67:353-8. 2014
  2. doi request reprint Update on interventional cardiology
    Jose M de la Torre Hernandez
    Unidad de Cardiologia Intervencionista, Servicio de Cardiologia, Hospital Universitario Marques de Valdecilla, Santander, Spain Electronic address
    Rev Esp Cardiol (Engl Ed) 66:282-9. 2013
  3. doi request reprint Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries
    Jose M de la Torre Hernandez
    Unidad de Cardiologia Intervencionista, Servicio de Cardiologia, Hospital Marques de Valdecilla, Santander, Spain Electronic address
    JACC Cardiovasc Interv 7:244-54. 2014
  4. ncbi request reprint A real all-comers randomized trial comparing Xience Prime and Promus Element stents
    Jose M de la Torre Hernandez
    Unidad de Hemodinámica y Cardiología Intervencionista, Hospital Universitario Marques de Valdecilla, 39012 Santander, Spain
    J Invasive Cardiol 25:182-5. 2013
  5. doi request reprint Comparison of paclitaxel-eluting stents (Taxus) and everolimus-eluting stents (Xience) in left main coronary artery disease with 3 years follow-up (from the ESTROFA-LM registry)
    Jose M de la Torre Hernandez
    Hospital M de Valdecilla, Santander, Spain
    Am J Cardiol 111:676-83. 2013
  6. doi request reprint [Update on interventional cardiology]
    Jose M de la Torre Hernandez
    Unidad de Cardiologia Intervencionista, Cardiología Valdecilla, Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Espana
    Rev Esp Cardiol (Engl Ed) 65:4-11. 2012
  7. doi request reprint Papillary muscle rupture: first report of this complication in a retrograde transfemoral aortic valve implantation
    Jose M de la Torre Hernandez
    Unidad de Cardiologia Intervencionista, Servicio de Cardiologia, Hospital Universitario Marques de Valdecilla, Santander, Spain
    Catheter Cardiovasc Interv 78:647-9. 2011
  8. doi request reprint Thrombosis of second-generation drug-eluting stents in real practice results from the multicenter Spanish registry ESTROFA-2 (Estudio Español Sobre Trombosis de Stents Farmacoactivos de Segunda Generacion-2)
    Jose M de la Torre Hernandez
    Interventional Cardiology Department, Unidad de Hemodinámica y Cardiología Intervencionista, Hospital Universitario Marques de Valdecilla, Instituto de Formación e Investigación Marqués de Valdecilla, Santander, Spain
    JACC Cardiovasc Interv 3:911-9. 2010
  9. ncbi request reprint Impact of drug eluting stents on the clinical practice of revascularisation of coronary artery disease
    Jose M de la Torre-Hernandez
    Unidad de Hemodinámica y Cardiología Intervencionista, Hospital Universitario Marques de Valdecilla, Santander, Spain
    EuroIntervention 5:460-4. 2009
  10. ncbi request reprint Late acquired incomplete stent apposition: incidence, mechanisms and clinical implications
    Jose M de la Torre Hernandez
    Unidad de Hemodinámica y Cardiología Intervencionista, Hospital Universitario, Marques de Valdecilla, Santander, Spain
    EuroIntervention 5:D112-20. 2009

Collaborators

Detail Information

Publications25

  1. doi request reprint Effectiveness and safety beyond 10 years of percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy
    Jose M de la Torre Hernandez
    Unidad de Hemodinámica y Cardiología Intervencionista, Servicio de Cardiologia, Hospital Universitario Marques de Valdecilla, Santander, Spain Electronic address
    Rev Esp Cardiol (Engl Ed) 67:353-8. 2014
    ..However, due to the relatively new introduction of this technique, there is no information on its very long term results (>10 years)...
  2. doi request reprint Update on interventional cardiology
    Jose M de la Torre Hernandez
    Unidad de Cardiologia Intervencionista, Servicio de Cardiologia, Hospital Universitario Marques de Valdecilla, Santander, Spain Electronic address
    Rev Esp Cardiol (Engl Ed) 66:282-9. 2013
    ..Finally, renal denervation is currently being widely discussed in the literature. ..
  3. doi request reprint Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries
    Jose M de la Torre Hernandez
    Unidad de Cardiologia Intervencionista, Servicio de Cardiologia, Hospital Marques de Valdecilla, Santander, Spain Electronic address
    JACC Cardiovasc Interv 7:244-54. 2014
    ..This study sought to investigate the clinical impact of the use of intravascular ultrasound (IVUS) during revascularization of patients with left main coronary artery (LM) disease with drug-eluting stents (DES)...
  4. ncbi request reprint A real all-comers randomized trial comparing Xience Prime and Promus Element stents
    Jose M de la Torre Hernandez
    Unidad de Hemodinámica y Cardiología Intervencionista, Hospital Universitario Marques de Valdecilla, 39012 Santander, Spain
    J Invasive Cardiol 25:182-5. 2013
    ..Recently, a new EES with a platinum-based platform (PtCr-EES) has been introduced in the market. There is only one study comparing both stents, but with important exclusion criteria...
  5. doi request reprint Comparison of paclitaxel-eluting stents (Taxus) and everolimus-eluting stents (Xience) in left main coronary artery disease with 3 years follow-up (from the ESTROFA-LM registry)
    Jose M de la Torre Hernandez
    Hospital M de Valdecilla, Santander, Spain
    Am J Cardiol 111:676-83. 2013
    ..The use of bifurcation stenting techniques in distal lesions was a relevant independent predictor for events. The use of intravascular ultrasound appears to have a positive impact on patients treated for LM distal disease...
  6. doi request reprint [Update on interventional cardiology]
    Jose M de la Torre Hernandez
    Unidad de Cardiologia Intervencionista, Cardiología Valdecilla, Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Espana
    Rev Esp Cardiol (Engl Ed) 65:4-11. 2012
    ....
  7. doi request reprint Papillary muscle rupture: first report of this complication in a retrograde transfemoral aortic valve implantation
    Jose M de la Torre Hernandez
    Unidad de Cardiologia Intervencionista, Servicio de Cardiologia, Hospital Universitario Marques de Valdecilla, Santander, Spain
    Catheter Cardiovasc Interv 78:647-9. 2011
    ..We found papillary muscle head calcification as an anatomical substrate that could facilitate this complication...
  8. doi request reprint Thrombosis of second-generation drug-eluting stents in real practice results from the multicenter Spanish registry ESTROFA-2 (Estudio Español Sobre Trombosis de Stents Farmacoactivos de Segunda Generacion-2)
    Jose M de la Torre Hernandez
    Interventional Cardiology Department, Unidad de Hemodinámica y Cardiología Intervencionista, Hospital Universitario Marques de Valdecilla, Instituto de Formación e Investigación Marqués de Valdecilla, Santander, Spain
    JACC Cardiovasc Interv 3:911-9. 2010
    ..This study sought to evaluate second-generation drug-eluting stent (DES) thrombosis in clinical practice...
  9. ncbi request reprint Impact of drug eluting stents on the clinical practice of revascularisation of coronary artery disease
    Jose M de la Torre-Hernandez
    Unidad de Hemodinámica y Cardiología Intervencionista, Hospital Universitario Marques de Valdecilla, Santander, Spain
    EuroIntervention 5:460-4. 2009
    ..This has expanded the application of percutaneous intervention (PCI). In this study we address the impact of the high DES penetration on the management of patients referred for coronary angiography...
  10. ncbi request reprint Late acquired incomplete stent apposition: incidence, mechanisms and clinical implications
    Jose M de la Torre Hernandez
    Unidad de Hemodinámica y Cardiología Intervencionista, Hospital Universitario, Marques de Valdecilla, Santander, Spain
    EuroIntervention 5:D112-20. 2009
    ..There is no evidence that correction of LAISA should be a target for secondary or repeated revascularisation. Benefits and risks of LAISA correction are unknown...
  11. doi request reprint Virtual histology intravascular ultrasound assessment of cardiac allograft vasculopathy from 1 to 20 years after heart transplantation
    Jose M de la Torre Hernandez
    Interventional Cardiology Department, Servicio de Cardiologia, Hospital Universitario Marques de Valdecilla, Santander, Spain
    J Heart Lung Transplant 28:156-62. 2009
    ..We sought to characterize graft coronary artery disease by means of IVUS-virtual histology (IVUS-VH) at different time-points of follow-up and to correlate plaque composition with clinical factors...
  12. doi request reprint Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos)
    Jose M de la Torre-Hernandez
    Hospital Marques de Valdecilla, Santander, Spain
    J Am Coll Cardiol 51:986-90. 2008
    ..This study sought to assess the incidence, predictors, and outcome of drug-eluting stent(DES) thrombosis in real-world clinical practice...
  13. ncbi request reprint [Treatment of lesions with a high risk of stenosis. Comparative study in 300 patients of rapamycin- and Paclitaxel-eluting polymer-based stents, and bare metal stents]
    Jose M de la Torre Hernandez
    Unidad de Hemodinámica y Cardiología Intervencionista, Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain
    Rev Esp Cardiol 58:262-9. 2005
    ..This prospective study compared their safety and efficacy in lesions with a high risk of restenosis...
  14. ncbi request reprint [Prospective use of an intravascular ultrasound-derived minimum lumen area cut-off value in the assessment of intermediate left main coronary artery lesions]
    Jose M de la Torre Hernandez
    Unidad de Hemodinámica y Cardiología Intervencionista, Hospital Universitario Marques de Valdecilla, Santander, Spain
    Rev Esp Cardiol 60:811-6. 2007
    ..The aim of this study was to determine the long-term safety of applying a cut-off value of 6 mm2 for the MLA in the LMCA...
  15. ncbi request reprint Coronary angiography with flat panel digital detectors significantly increases the sensitivity for calcium detection in relation to conventional fluoroscopy: comparison of both systems with intravascular ultrasound
    Jose M de la Torre Hernandez
    Unidad de Hemodinamica, Hospital Marques de Valdecilla, Avda Valdecilla s n, Santander, 39008, Spain
    J Invasive Cardiol 17:365-8. 2005
    ....
  16. ncbi request reprint [Sirolimus-eluting stents to treat lesions with a high risk of restenosis. Six-month clinical follow-up in the first 100 patients]
    Jose M de la Torre Hernandez
    Unidad de Hemodinámica y Cardiología Intervencionista, Hospital Universitario Marques de Valdecilla, Santander, Espana
    Rev Esp Cardiol 57:116-22. 2004
    ..We decided to assess their usefulness in lesions with a high risk of restenosis...
  17. doi request reprint Comparison of paclitaxel-eluting vs. everolimus-eluting stents implanted simultaneously in different lesions of the same coronary artery: 12-month follow-up with optical coherence tomography
    Jose M de la Torre Hernandez
    Unidad de Cardiologia Intervencionista, Cardiología Valdecilla, Hospital Universitario Marques de Valdecilla, Santander, Spain
    EuroIntervention 9:952-8. 2013
    ..This study sought to assess and compare long-term coverage and apposition of PES and EES implanted in different lesions of the same coronary artery (and in the same patient)...
  18. doi request reprint Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study
    Jose M de la Torre Hernandez
    Hospital Marques de Valdecilla, IFIMAV, Santander, Spain
    J Am Coll Cardiol 58:351-8. 2011
    ..This study is a prospective validation of 6 mm(2) as a minimum lumen area (MLA) cutoff value for revascularization of left main coronary artery (LMCA) lesions...
  19. ncbi request reprint [Findings with a pressure guide wire in acute coronary syndrome]
    Jose M de la Torre Hernandez
    Unidad de Hemodinámica y Cardiología Intervencionista, Hospital Marques de Valdecilla, Santander, Spain
    Rev Esp Cardiol 55:438. 2002
  20. ncbi request reprint [Two-year clinical follow-up in 200 patients receiving sirolimus-eluting stents in lesions at a high risk of restenosis]
    Jose M de la Torre-Hernandez
    Unidad de Hemodinámica y Cardiología Intervencionista, Hospital Universitario Marques de Valdecilla, Santander, Espana
    Rev Esp Cardiol 59:225-31. 2006
    ..Our aim was to evaluate long-term outcome in patients undergoing SES placement in lesions at a high risk of restenosis...
  21. ncbi request reprint [Importance of severe lesions left untreated in patients with acute coronary syndromes and angioplasty of the culprit lesion]
    Jose M de la Torre Hernandez
    Unidad de Cardiología Intervencionista Hospital Universitario Marqués de Valdecilla Santander España
    Rev Esp Cardiol 56:761-8. 2003
    ..We investigated whether these lesions were prone to become unstable since they exist within a prothrombotic and inflammatory systemic milieu...
  22. ncbi request reprint [Electrocardiographic prediction of the site of lesion in the anterior descending artery in acute myocardial infarction]
    José A Prieto Solís
    Unidad Coronaria Hospital Marqués de Valdecilla Santander España
    Rev Esp Cardiol 55:1028-35. 2002
    ....
  23. ncbi request reprint Comparison of C-reactive protein levels after coronary stenting with bare metal versus sirolimus-eluting stents
    Jose M de la Torre-Hernandez
    Interventional Cardiology Department, Hospital Universitario Marques de Valdecilla, Santander, Spain
    Am J Cardiol 95:748-51. 2005
    ....
  24. ncbi request reprint [Update in interventional cardiology]
    Jose M de la Torre Hernandez
    Unidad de Cardiologia Intervencionista, Servicio de Cardiologia, Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Espana
    Rev Esp Cardiol 64:13-9. 2011
    ..Finally, there is increasing interest in the percutaneous treatment of structural heart disease, particularly percutaneous aortic valve implantation...
  25. doi request reprint Clinical outcomes after intravascular ultrasound and fractional flow reserve assessment of intermediate coronary lesions. Propensity score matching of large cohorts from two institutions with a differential approach
    Jose M de la Torre Hernandez
    Unidad de Cardiologia Intervencionista, Cardiología Valdecilla, Hospital Universitario Marques de Valdecilla, Santander, Spain
    EuroIntervention 9:824-30. 2013
    ..7). Conclusions: IVUS and FFR may be safely used to defer revascularisation of intermediate lesions. IVUS induces a higher degree of revascularisation but much lower than previously reported and does not affect the clinical outcome. ..